Medigene’s focus is developing cell therapies from a patient’s own cells, engineering them with a T cell receptor (TCR) that targets an antigen on a cancer cell. Under the deal announced Tuesday, the ...

Cesar M. Castro, MD, MSc, of the Department of Medicine and Center for Systems Biology at Massachusetts General Hospital, and Hakho Lee, PhD, of the Department of Radiology and Center for Systems ...

Appendix cancer rates have tripled in Gen X and quadrupled in millennials. Here's what researchers know about this rare ...

New Day will not only connect patients, families and caregivers to cancer resources, but also address logistical and ...

Cancer is a devastating disease that causes one in six deaths globally. A large proportion of these deaths could be prevented, but improving prevention and treatment outcomes requires accurate ...

OraCare is expanding the scope of its cancer patient support program, OraCare Cares. The company plans to do an in-kind donation of its OraCare Rinse to cancer patients experiencing oral side effects ...